TNF and hepatocellular carcinoma: As demonstrated in clinical trials, metformin can inhibit the trained immunity property of BCG by reducing the production of IL‐6 and Tumor necrosis factor‐α (TNF‐α).[21] To investigate the contribution of trained immunity to the anti‐HCC effect of BCG, metformin was administered alone or in combination with BCG to HCC mice.